Vimarsana
Biggest News Aggregation in the World

Although Eupraxia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Although Eupraxia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Although Eupraxia Today - Breaking & Trending Today

Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis - Vimarsana News

Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals...

Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today - Vimarsana News

Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today

VICTORIA, BC, April 5, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ; , a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology to optimize drug delivery...

Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024 - Vimarsana News

Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024

Company's Listing Application Approved by Nasdaq VICTORIA, BC, April 3, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ; , a clinical-stage biotechnology company leveraging its proprietary...

Eupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering of $30 Million - Vimarsana News

Eupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering of $30 Million

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 12, 2024 -- Eupraxia Pharmaceuticals Inc. , a clinical-stage biotechnology company,...

Eupraxia Pharmaceuticals Announces Overnight Marketed - Vimarsana News

Eupraxia Pharmaceuticals Announces Overnight Marketed

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) -- Eupraxia...